Form 4: Cyanotech Corp: Chief Scientific Officer Cysewski Reports Stock Transactions

Gerald R Cysewski, Chief Scientific Officer of Cyanotech Corp, reports the vesting of restricted stock units and subsequent withholding of shares for tax liabilities.

Summary

• On February 18, 2025, Gerald R Cysewski, the Chief Scientific Officer of Cyanotech Corp, reported transactions involving common stock and restricted stock units.
• 3,900 restricted stock units vested and were converted into common stock.
• The company withheld 1,464 shares to cover payroll tax liabilities related to the vesting.
• Following these transactions, Cysewski directly owns 145,692 shares of common stock and indirectly owns 250 shares held by his spouse.
• He also owns 1,644 restricted stock units.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions, with no inherent positive or negative sentiment.

Future Outlook

The remaining restricted stock units will vest on April 6, 2025, July 29, 2025 and April 6, 2026, subject to continued service with the company.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, which is a common practice for publicly traded companies. It provides transparency into the trading activities of company executives and directors.

Stakeholder Impact

• The transaction has a minor impact on shareholders as it reflects the vesting of previously granted compensation.

Key Dates

Keywords

Cyanotech, Cysewski, Restricted Stock Units, Common Stock, Vesting, Form 4, Insider Trading, Payroll Tax, Beneficial Ownership